Gogoro (NASDAQ:GGR) reported $90.70 million in sales this quarter. This is a 5.32 percent increase over sales of $86.12 million the same period last year.
Gogoro Q2 Sales $90.70M Up From $86.12M YoY
Gogoro (NASDAQ:GGR) reported $90.70 million in sales this quarter. This is a 5.32 percent increase over sales of $86.12 million the same period last year.
Related Posts
Prescription Race: Amazon Ramps Up Same-Day Delivery In Major Cities
March 26, 1:00 PM
Amazon (NASDAQ:AMZN) Expands Pharmacy Delivery to New York and Los Angeles: Same-Day Service for Common Prescriptions" - AMZN extends pharmacy delivery to major cities, offering quick access to essential medications like flu treatments and blood pressure management. Expansion plans include over a dozen U.S. cities by year-end, leveraging small-format facilities for efficient stock management and faster delivery options.
Merck’s Crown Jewel Cancer Drug Keytruda Scores FDA Approval For Third Indication In Cervical Cancer
January 16, 12:10 PM
FDA approves Merck's Keytruda for advanced cervical cancer. Keytruda plus chemoradiotherapy shows a 41% improvement in progression-free survival.
AvidXchange Launches End-To-End Purchase-To-Pay Integration For Acumatica
July 11, 9:08 AM
https://www.avidxchange.com/solutions/avidsuite-for-acumatica/